Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Five Years Follow up: Add on Intravenous Ketamine for Major Depressive Disorder

NCT04238039 is registered in ClinicalTrials.gov with The Chaim Sheba Medical Center as lead sponsor.

NCT NCT04238039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04238039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Five Years Follow up: Add on Intravenous Ketamine for Major Depressive Disorder
Lead sponsor
The Chaim Sheba Medical Center
Phase
Observational
Overall status
Unknown status
Start date
December 14, 2019
Completion date
April 1, 2020
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

followin ketamine treatment